Nov 14, 2025 4:01pm EST Inhibikase Therapeutics Announces Third Quarter 2025 Financial Results and Highlights Recent Activity
Aug 19, 2025 8:00am EDT Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer